Literatur
Kastrinos F, Uno H, Ukaegbu C et al (2017) Development and validation of the PREMM5 model for comprehensive risk assessment of lynch syndrome. J Clin Oncol 35:2165–2172
Chen S, Wang W, Lee S et al (2006) Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA 296:1479–1487
Parmigiani G, Berry D, Aguilar O (1998) Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 62:145–158
National Comprehensive Cancer Network Clinical Practice Guidelines: Genetic/familial high-risk assessment: Colorectal (Version 1.2021). https:// www.nccn.org/professionals/physician_gls/pdf/genetics_colon.pdf
National Comprehensive Cancer Network Clinical Practice Guidelines: Genetic/familial high-risk assessment: Breast, ovarian, and pancreatic (Version 1.2022). https://www.nccn.org/professionals/physician_gls/pdf/genetics_bop.pdf
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
A.G. Barutcu und H. Alakus geben an, dass kein Interessenkonflikt besteht.
Additional information
QR-Code scannen & Beitrag online lesen
Rights and permissions
About this article
Cite this article
Barutcu, A.G., Alakus, H. Klinische Evaluation des erblichen Krebsrisikos. Onkologie 29, 72–73 (2023). https://doi.org/10.1007/s00761-022-01255-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00761-022-01255-z